Inventor
VOS TRICIA J
US23 patents
⚠️ This page may combine multiple inventors who share the name “VOS TRICIA J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MILLENNIUM PHARM INC
13 patentsUS6699873B1Mar 2, 2004
Melanocortin-4 receptor binding compounds and methods of use thereof
MILLENNIUM PHARM INC86 citations96
US7572784B2Aug 11, 2009
Compounds and methods for inhibiting mitotic progression
MILLENNIUM PHARM INC38 citations95
US9765078B2Sep 19, 2017
Compounds and methods for inhibiting mitotic progression
MILLENNIUM PHARM INC11 citations92
US9102678B2Aug 11, 2015
Compounds and methods for inhibiting mitotic progression
MILLENNIUM PHARM INC13 citations92
US10414770B2Sep 17, 2019
Compounds and methods for inhibiting mitotic progression
MILLENNIUM PHARM INC1 citations72
US10202373B2Feb 12, 2019
Heteroaryls and uses thereof
MILLENNIUM PHARM INC2 citations71
US9802960B2Oct 31, 2017
Heteroaryls and uses thereof
MILLENNIUM PHARM INC4 citations71
US9751854B2Sep 5, 2017
Heteroaryls and uses thereof
MILLENNIUM PHARM INC3 citations71
US11014928B2May 25, 2021
Compounds and methods for inhibiting mitotic progression
MILLENNIUM PHARM INC0 citations62
US7795249B2Sep 14, 2010
Certain pyrazoline derivatives with kinase inhibitory activity
MILLENNIUM PHARM INC3 citations57
US10538533B2Jan 21, 2020
Heteroaryls and uses thereof
MILLENNIUM PHARM INC0 citations50
US7998952B2Aug 16, 2011
Thiolactams and uses thereof
MILLENNIUM PHARM INC0 citations49
US7652041B2Jan 26, 2010
Cinnamide and hydrocinnamide derivatives with kinase inhibitory activity
MILLENNIUM PHARM INC1 citations48
ORE PHARMACEUTICALS INC
3 patentsUS7790719B2Sep 7, 2010
Modulators of melanocortin receptor
ORE PHARMACEUTICALS INC7 citations69
US7365070B2Apr 29, 2008
Modulators of melanocortin receptor
ORE PHARMACEUTICALS INC2 citations58
US7375125B2May 20, 2008
Melanocortin-4 receptor binding compounds and methods of use thereof
ORE PHARMACEUTICALS INC1 citations50